1. Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC. Issue 10 (October 2019) Authors: Kar, Adwitiya; Zhang, Yu; Yacob, Betelehem W; Saeed, Jordan; Tompkins, Kenneth D; Bagby, Stacey M; Pitts, Todd M; Somerset, Hilary; Leong, Stephen; Wierman, Margaret E; Kiseljak-Vassiliades, Katja Journal: Endocrine-related cancer Issue: Volume 26:Issue 10(2019) Page Start: 765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗